Nasus Pharma Ltd. (NSRX) — Defensive Interval Ratio
Nasus Pharma Ltd. (NSRX) has a Defensive Interval Ratio of 515 days as of December 2025. Defensive assets of $3.05 Million (cash $-, short-term investments $3.05 Million, receivables $-) cover 515 days of daily cash needs of $5.93K/day. See NSRX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Nasus Pharma Ltd. Defensive Interval Ratio (2024–2025)
This chart shows how Nasus Pharma Ltd.'s Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 515 days, meaning defensive assets of $3.05 Million can fund 515 days of operations without new revenue. See NSRX net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Nasus Pharma Ltd. (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Nasus Pharma Ltd. from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Nasus Pharma Ltd. stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 515 days | $3.05 Million | $5.93K/day | $- | $3.05 Million | ▲ +515 days |
| 2024 | 0 days | $0.00 | $10.76K/day | $- | $0.00 | — |